Overview

Update
Status
Acquired by on May 8, 2015
Total Equity Funding
$6.19M in 1 Round from 2 Investors
Description:
Lanthio Pharma is focused on the research and development of therapeutic lantipeptide drugs for serious diseases.
Categories:
Pharmaceutical, Therapeutics, Biotechnology
Website:
http://www.lanthiopharma.com

Company Details

Update

Lanthio Pharma is a privately held drug discovery company that applies its proprietary lanthionine-peptide drug discovery technology LanthioPepTM for the generation of novel peptide therapeutics with increased resistance to peptidase degradation, high receptor specificity and increased intrinsic activity. Lanthio Pharma has generated stable, peptidase-resistant lanthionine peptides with highly specific agonistic activity for a number of GPCR targets, which is a focus area of the company.

Funding Rounds (2) - $11.12M

Update
DateAmount / RoundValuationLead InvestorInvestors
May, 2014€3.6M / Debt Financing0
Nov, 2012€4.8M / Series A2

Investors (2)

InvestorRound(s)Partner(s)
Series A (Lead)-
Series A (Lead)-

Offices/Locations (2)

Update
  • Office

    Nijenborgh 4

    9747 AG Groningen

    ,

    The Netherlands

  • Office

    Groningen,

    NLD

Images (1)

Update

Add Acquisitions

Add Current Team

Add Board Members and Advisors

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos